Literature DB >> 19673961

Aetiology of, and risk factors for, recurrent community-acquired pneumonia.

C Garcia-Vidal1, J Carratalà, N Fernández-Sabé, J Dorca, R Verdaguer, F Manresa, F Gudiol.   

Abstract

Recurrent community-acquired pneumonia (CAP) requiring hospitalization is a matter of particular concern. However, current information on its prevalence, aetiology and risk factors is lacking. To address these issues, we performed an observational analysis of a prospective cohort of hospitalized adults with CAP. Recurrence was defined as two or more episodes of CAP 1 month apart within 3 years. Patients with severe immunosuppression or local predisposing factors were excluded. Of the 1556 patients, 146 (9.4%) had recurrent CAP. The most frequent causative organism was Streptococcus pneumoniae, both in patients with recurrent CAP and in those without recurrence. Haemophilus influenzae, other Gram-negative bacilli and aspiration pneumonia were more frequent among patients with recurrent CAP, whereas Legionella pneumophila was rarely identified in this group. Independent factors associated with recurrent CAP were greater age, lack of pneumococcal vaccination, chronic obstructive pulmonary disease (COPD) and corticosteroid therapy. In a sub-analysis of 389 episodes of pneumococcal pneumonia, the only independent risk factor for recurrence was lack of pneumococcal vaccination. Recurrence of CAP is not a rare clinical problem and it occurs mainly in the elderly, patients with COPD, and those receiving corticosteroids. Our study provides support for recommending pneumococcal vaccination for adults at risk of pneumonia, including those with a first episode of CAP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673961     DOI: 10.1111/j.1469-0691.2009.02918.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Microbiological Characterization of Haemophilus influenzae Isolated from Patients with Lower Respiratory Tract Infections in a Tertiary Care Hospital, South India.

Authors:  Padmaja Ananth Shenoy; Kiran Chawla; Shashidhar Vishwanath; Dipika Shaw
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 3.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

Review 4.  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

Authors:  M H Rozenbaum; P Pechlivanoglou; T S van der Werf; J R Lo-Ten-Foe; M J Postma; E Hak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-14       Impact factor: 3.267

5.  Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: the Health, Aging, and Body Composition Study.

Authors:  Manisha Juthani-Mehta; Nathalie De Rekeneire; Heather Allore; Shu Chen; John R O'Leary; Douglas C Bauer; Tamara B Harris; Anne B Newman; Sachin Yende; Robert J Weyant; Stephen Kritchevsky; Vincent Quagliarello
Journal:  J Am Geriatr Soc       Date:  2013-06-17       Impact factor: 5.562

6.  Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up.

Authors:  T T Dang; D T Eurich; D L Weir; T J Marrie; S R Majumdar
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

Review 7.  Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  L Hogerwerf; B DE Gier; B Baan; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2017-09-26       Impact factor: 4.434

8.  Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used.

Authors:  Paul Zarogoulidis; Ioanna Alexandropoulou; Gioulia Romanidou; Theocharis G Konstasntinidis; Eirini Terzi; S Saridou; Athanasios Stefanis; Kostas Zarogoulidis; T C Constantinidis
Journal:  Int J Gen Med       Date:  2011-01-06

9.  Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

Authors:  Silvia Fernández-Serrano; Jordi Dorca; Carolina Garcia-Vidal; Núria Fernández-Sabé; Jordi Carratalà; Ana Fernández-Agüera; Mercè Corominas; Susana Padrones; Francesc Gudiol; Frederic Manresa
Journal:  Crit Care       Date:  2011-03-15       Impact factor: 9.097

10.  Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.

Authors:  Francesco Blasi; Javier Garau; Jesús Medina; Marco Ávila; Kyle McBride; Helmut Ostermann
Journal:  Respir Res       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.